Atıf Formatları
A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. KAVAL Et Al. , "A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation," 13th International Symposium on Pharmaceutical Science , Ankara, Turkey, 2021

KAVAL, B. Et Al. 2021. A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation. 13th International Symposium on Pharmaceutical Science , (Ankara, Turkey).

KAVAL, B., ÖZCAN, S., & KAYNAK, M. S., (2021). A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation . 13th International Symposium on Pharmaceutical Science, Ankara, Turkey

KAVAL, BERNA, SANİYE ÖZCAN, And MUSTAFA SİNAN KAYNAK. "A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation," 13th International Symposium on Pharmaceutical Science, Ankara, Turkey, 2021

KAVAL, BERNA Et Al. "A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation." 13th International Symposium on Pharmaceutical Science , Ankara, Turkey, 2021

KAVAL, B. ÖZCAN, S. And KAYNAK, M. S. (2021) . "A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation." 13th International Symposium on Pharmaceutical Science , Ankara, Turkey.

@conferencepaper{conferencepaper, author={BERNA KAVAL Et Al. }, title={A novel RP-HPLC method to determine irbesartan and hydrochlorothiazide in fixed dose combinations: method development and validation}, congress name={13th International Symposium on Pharmaceutical Science}, city={Ankara}, country={Turkey}, year={2021}}